Severe bacterial endophthalmitis: towards improving clinical outcomes
about
In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal EndophthalmitisDaptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study.Endogenous endophthalmitis: diagnosis, management, and prognosis.Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.
P2860
Severe bacterial endophthalmitis: towards improving clinical outcomes
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Severe bacterial endophthalmitis: towards improving clinical outcomes
@en
type
label
Severe bacterial endophthalmitis: towards improving clinical outcomes
@en
prefLabel
Severe bacterial endophthalmitis: towards improving clinical outcomes
@en
P2860
P356
P1476
Severe bacterial endophthalmitis: towards improving clinical outcomes
@en
P2093
Billy D Novosad
Michelle C Callegan
P2860
P304
P356
10.1586/EOP.10.52
P577
2010-10-01T00:00:00Z